Smith CA - Search Results

1

Identification of a source of biologically active CD40 ligand.

Armitage RJ, Sato TA, Macduff BM, Clifford KN, Alpert AR, Smith CA, Fanslow WC. Armitage RJ, et al. Among authors: smith ca. Eur J Immunol. 1992 Aug;22(8):2071-6. doi: 10.1002/eji.1830220817. Eur J Immunol. 1992. PMID: 1379186

2

Molecular and biological characterization of human 4-1BB and its ligand.

Alderson MR, Smith CA, Tough TW, Davis-Smith T, Armitage RJ, Falk B, Roux E, Baker E, Sutherland GR, Din WS. Alderson MR, et al. Among authors: smith ca. Eur J Immunol. 1994 Sep;24(9):2219-27. doi: 10.1002/eji.1830240943. Eur J Immunol. 1994. PMID: 8088337

3

Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48.

Kubin MZ, Parshley DL, Din W, Waugh JY, Davis-Smith T, Smith CA, Macduff BM, Armitage RJ, Chin W, Cassiano L, Borges L, Petersen M, Trinchieri G, Goodwin RG. Kubin MZ, et al. Among authors: smith ca. Eur J Immunol. 1999 Nov;29(11):3466-77. doi: 10.1002/(SICI)1521-4141(199911)29:11<3466::AID-IMMU3466>3.0.CO;2-9. Eur J Immunol. 1999. PMID: 10556801 Free article.

4

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.

Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Gruss HJ, et al. Among authors: smith ca. Blood. 1994 Apr 15;83(8):2045-56. Blood. 1994. PMID: 8161776 Free article.

5

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Goodwin RG, Alderson MR, Smith CA, Armitage RJ, VandenBos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, et al. Goodwin RG, et al. Among authors: smith ca. Cell. 1993 May 7;73(3):447-56. doi: 10.1016/0092-8674(93)90133-b. Cell. 1993. PMID: 8387892

6

Regulation of murine B cell growth and differentiation by CD30 ligand.

Shanebeck KD, Maliszewski CR, Kennedy MK, Picha KS, Smith CA, Goodwin RG, Grabstein KH. Shanebeck KD, et al. Among authors: smith ca. Eur J Immunol. 1995 Aug;25(8):2147-53. doi: 10.1002/eji.1830250805. Eur J Immunol. 1995. PMID: 7664777

7

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC. Wiley SR, et al. Among authors: smith ca. Immunity. 2001 Nov;15(5):837-46. doi: 10.1016/s1074-7613(01)00232-1. Immunity. 2001. PMID: 11728344 Free article.

8

Reverse signaling via CD30 ligand.

Wiley SR, Goodwin RG, Smith CA. Wiley SR, et al. Among authors: smith ca. J Immunol. 1996 Oct 15;157(8):3635-9. J Immunol. 1996. PMID: 8871664

9

Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.

Degli-Esposti MA, Davis-Smith T, Din WS, Smolak PJ, Goodwin RG, Smith CA. Degli-Esposti MA, et al. Among authors: smith ca. J Immunol. 1997 Feb 15;158(4):1756-62. J Immunol. 1997. PMID: 9029113

10

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, et al. Smith CA, et al. Cell. 1993 Jul 2;73(7):1349-60. doi: 10.1016/0092-8674(93)90361-s. Cell. 1993. PMID: 8391931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,998 results

Search Page

Filters